Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.

Johnson & Johnson (JNJ) stock climbed after reporting Q1 2026 earnings that beat forecasts, posting $24.1B sales and raising ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

Bengaluru: French drugmaker Sanofi said on Friday ​the European ​Medicines Agency has recommended the approval of ​a subcutaneous version of its blood cancer drug administered through an ...

Pembro, made by pharma giant MSD, is hailed as a drug that saves and prolongs lives but it comes at an exorbitant cost ...

Amgen announces encouraging results in a Phase 3 trial for a new treatment of thyroid eye disease. Viridian Therapeutics is ...

Taking action early — even before you notice symptoms — can make it easier to manage your spring allergies.

Two Alzheimer's drugs were hailed as treatments that would transform care. Why are barely any UK patients getting them?

You can now choose between GLP-1 pills or shots for weight loss. Here's what you need to know to decide which one is best for ...